[Can post-ERCP acute pancreatitis be predicted and prevented?].
Service d'Hépato-Gastro-Entérologie, Hôpital Sainte Marguerite, Marseille.
L
L
Heyries
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000009:adverse effects*; D003287:Contrast Media; D016670:Gabexate / Q000627:therapeutic use; D006801:Humans; D015282:Octreotide / Q000627:therapeutic use; D010195:Pancreatitis / Q000175:diagnosis* / Q000209:etiology / Q000517:prevention & control*; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use; D013004:Somatostatin / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D003287:Contrast Media; D015842:Serine Proteinase Inhibitors; D016670:Gabexate; D013004:Somatostatin; D015282:Octreotide